A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
for Sickle Cell Disease
16 locations incl. Oakland
Sponsor: Editas Medicine, Inc.
Sex: All·Age: 12 - 50
Code: NCT06363760·Enrolling By Invitation